OUTLOOK THERAPEUTICS INC (OTLK) Stock Analysis

OUTLOOK THERAPEUTICS INC (OTLK) is a publicly traded company in the HEALTHCARE sector. It trades at $0.84, carries a market capitalization of $125.26M. This page summarizes the public market data, fundamentals, and frequently asked questions for OTLK, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

OUTLOOK THERAPEUTICS INC currently has a Bullish sentiment score of 0.28.

About OUTLOOK THERAPEUTICS INC

Outlook Therapeutics, Inc. is a late-stage biopharmaceutical firm based in Cranbury, New Jersey, dedicated to the development of pioneering monoclonal antibody therapies aimed at treating ocular diseases. The company focuses on addressing significant unmet medical needs within the ophthalmology field, with a robust pipeline targeting critical retinal conditions. As it advances towards regulatory approvals and potential commercialization, Outlook Therapeutics is well-positioned to enhance pati...

GNG Research Analysis

GNG Research scores OUTLOOK THERAPEUTICS INC (OTLK) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for OTLK.

Frequently Asked Questions

Does OTLK pay dividends?

OUTLOOK THERAPEUTICS INC (OTLK) does not currently pay a regular dividend.

What is OTLK's market cap?

OUTLOOK THERAPEUTICS INC (OTLK) has a market capitalization of $125.26M with a current stock price of $0.84.